Affordable Access

deepdyve-link
Publisher Website

Pretreatment metabolic tumor volumes to predict the short-term outcome of unresectable locally advanced squamous cell carcinoma of the esophagus treated with definitive chemoradiotherapy.

Authors
  • Chen, Shang-Wen1
  • Hsieh, Te-Chun
  • Ding, Hueisch-Jy
  • Yen, Kuo-Yang
  • Lin, Chen-Yuan
  • Liang, Ji-An
  • Kao, Chia-Hung
  • 1 aDepartment of Radiation Oncology bGraduate Institute of Clinical Medicine Science and School of Medicine, College of Medicine cDepartment of Nuclear Medicine and PET Center dDepartment of Biomedical Imaging and Radiological Science eDivision of Hematology and Oncology, China Medical University Hospital, Taichung fSchool of Medicine, Taipei Medical University, Taipei gDepartment of Medical Imaging and Radiological Sciences, I-Shou University, Kaohsiung, Taiwan. , (China)
Type
Published Article
Journal
Nuclear medicine communications
Publication Date
Mar 01, 2014
Volume
35
Issue
3
Pages
291–297
Identifiers
DOI: 10.1097/MNM.0000000000000046
PMID: 24276528
Source
Medline
License
Unknown

Abstract

Pretreatment MTV20% is a novel marker for OS and DFS in patients with unresectable locally advanced esophageal cancer treated with definitive chemoradiotherapy. Treatment intensification must be considered for patients with higher MTVs.

Report this publication

Statistics

Seen <100 times